Trier par
INIS
antibodies
10%
anticoagulants
7%
applications
6%
assessments
12%
automation
6%
biological markers
5%
blood
5%
bones
10%
breasts
12%
cancer
11%
capacity
5%
carbohydrates
7%
comparative evaluations
30%
concentration
5%
coronaviruses
10%
cost
10%
data
16%
defects
5%
delivery
7%
detection
5%
dimensions
10%
diseases
10%
doses
6%
endometrium
5%
estradiol
10%
estrogens
69%
evaluation
35%
fetuses
5%
global analysis
5%
globulins
10%
guidelines
10%
hemostatics
27%
hormones
24%
immunity
7%
in vitro
5%
information
5%
inhibition
5%
interlaboratory comparisons
10%
laboratories
23%
lipids
10%
membranes
6%
men
14%
menopause
10%
metabolism
10%
mutations
15%
patients
34%
performance
15%
planning
10%
plasma
5%
populations
11%
pregnancy
24%
progestin
10%
proteins
82%
range
14%
receptors
21%
reviews
51%
risks
65%
safety
18%
screening
20%
sensitivity
40%
sex
5%
standardization
17%
steroids
8%
surveys
7%
symptoms
23%
synthesis
6%
tamoxifen
10%
testing
14%
therapy
19%
thrombin
100%
thrombosis
13%
values
8%
wave forms
5%
women
81%
Pharmacology, Toxicology and Pharmaceutical Science
Activated Protein C
19%
Activated Protein C Resistance
36%
APC
14%
Bleeding
11%
Blood Stasis
15%
Diethylstilbestrol
5%
Disproportionality Analysis
10%
Drospirenone
11%
Estetrol
22%
Estrogen Derivative
6%
Estrogen Receptor
9%
Estrogen Receptor Positive Breast Cancer
10%
Ethinylestradiol
17%
Hemostatic Agent
16%
Infection
10%
Levonorgestrel
10%
Menopausal Syndrome
10%
Neutralizing Antibody
10%
Observational Study
10%
Oral Contraceptive
11%
Oral Contraceptive Agent
40%
Placebo
5%
Preference
10%
Progestin
7%
SARS Coronavirus
10%
Tamoxifen
10%
Thrombin
53%
Thrombogenicity
5%
Thrombosis
7%
Venous Thromboembolism
22%
Keyphrases
Activated Protein C
10%
Activated Protein C Resistance
6%
APC Resistance
10%
Bone Turnover
10%
Breast Cancer
10%
Breast Cancer Patients
10%
Childbearing Women
10%
Climacteric Symptoms
10%
Combined Oral Contraceptives
12%
Disproportionality Analysis
10%
Drospirenone
11%
Endogenous Thrombin Potential
6%
Estrogen Receptor
8%
Estrogen Receptor-positive Breast Cancer
10%
Ethinylestradiol
10%
EudraVigilance Database
10%
Factor V Leiden mutation
7%
Global Coagulation Tests
10%
Hemostasis Parameters
10%
High Users
5%
Hypercoagulability
10%
Levonorgestrel
6%
Literature Review Analysis
10%
Local Estrogen Therapy
5%
Membrane Estrogen Receptor
7%
Menopausal Symptoms
10%
Menopause Symptoms
10%
Modern Contraceptives
10%
Natural Estrogens
12%
Nuclear Estrogen Receptor
7%
Omicron Sub-lineages
10%
Oral Contraception
10%
Oral Contraceptives
10%
Panel Review
10%
Position Statement
10%
Postpartum Period
10%
Projet
5%
Randomized Double-blind Study
10%
Reporting Rate
6%
Sensitivity Ratio
14%
Stated Preference Studies
10%
Thrombin Generation Assay
6%
User Satisfaction
5%
Venous Thromboembolic Events
10%
Women's Preferences
5%